Economic burden of relapse/recurrence in patients with major depressive disorder

Objective: This study was conducted to determine the incremental healthcare resource utilization (HRU) and costs associated with relapse or recurrence (R/R) in patients with major depressive disorder (MDD) treated with antidepressants (AD) in US clinical practice. Methods: In this retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauthier, Genevieve, Mucha, Lisa, Shi, Sherry, Guerin, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542183/
https://www.ncbi.nlm.nih.gov/pubmed/31192030
http://dx.doi.org/10.1080/21556660.2019.1612410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542183/
https://www.ncbi.nlm.nih.gov/pubmed/31192030
http://dx.doi.org/10.1080/21556660.2019.1612410

Ejemplares similares